Clinical and Laboratory Features of PCR-Confirmed and Clinically Suspected COVID-19 Pediatric Patients: A Single Hospital-Based Experience During the First COVID-19 Wave in the United Arab Emirates.

COVID-19 SARS-CoV-2 United Arab Emirates children pediatrics

Journal

Frontiers in pediatrics
ISSN: 2296-2360
Titre abrégé: Front Pediatr
Pays: Switzerland
ID NLM: 101615492

Informations de publication

Date de publication:
2022
Historique:
received: 07 12 2021
accepted: 04 02 2022
entrez: 4 4 2022
pubmed: 5 4 2022
medline: 5 4 2022
Statut: epublish

Résumé

This study investigated clinical and laboratory differences between confirmed (RT-PCR-positive) and clinically suspected (RT-PCR-negative) COVID-19 pediatric patients, and explored factors associated with disease severity at presentation and duration of hospitalization. Medical charts of COVID-19-confirmed and clinically suspected pediatric patients admitted to a tertiary hospital in Abu Dhabi were reviewed. Sociodemographic information and clinical and laboratory outcomes were retrieved and analyzed. Between 1 April to 30 June, 2020, 173 patients (mean age: 3.6 ± SD 3.2 years) presented with respiratory symptoms. Of them, 18.0% had confirmed contact with COVID-19 cases, 66.5% had symptoms for ≤3 days, and 86.7% were with moderate to severe disease. Twenty-eight (16.1%) patients tested positive while the rest (83.8%) tested negative in RT-PCR. COVID-19-confirmed and clinically suspected patients were statistically similar ( In pediatric patients with negative RT-PCR, COVID-19 is still suspected based on clinical symptoms and epidemiological data. A tentative diagnosis can be made based on a thorough examination, and proper medical management can be initiated promptly.

Identifiants

pubmed: 35372173
doi: 10.3389/fped.2022.830587
pmc: PMC8965316
doi:

Types de publication

Journal Article

Langues

eng

Pagination

830587

Informations de copyright

Copyright © 2022 Eldin, Saleh, Labib, Othman, Chacko, Mae, Elnour and Al-Rifai.

Déclaration de conflit d'intérêts

The authors declare that the research was conducted in the absence of any commercial or financial relationships that could be construed as a potential conflict of interest.

Références

Eur J Pediatr. 2020 Jul;179(7):1029-1046
pubmed: 32424745
MMWR Morb Mortal Wkly Rep. 2021 Sep 10;70(36):1249-1254
pubmed: 34499628
N Engl J Med. 2020 Mar 26;382(13):1199-1207
pubmed: 31995857
Curr Med Sci. 2020 Apr;40(2):275-280
pubmed: 32207032
Front Pediatr. 2020 Jul 03;8:431
pubmed: 32719759
Innovation (N Y). 2020 Nov 25;1(3):100061
pubmed: 33169119
Front Pediatr. 2021 Jan 18;8:603741
pubmed: 33537264
N Engl J Med. 2020 Jul 9;383(2):187-190
pubmed: 32356945
Pediatrics. 2020 Jun;145(6):
pubmed: 32179660
Lancet Infect Dis. 2020 Jun;20(6):689-696
pubmed: 32220650
Saudi Med J. 2021 Apr;42(4):391-398
pubmed: 33795494
J Korean Med Sci. 2020 Jun 29;35(25):e236
pubmed: 32597047
JAMA Intern Med. 2020 Jul 1;180(7):934-943
pubmed: 32167524
Pediatr Pulmonol. 2020 Oct;55(10):2565-2575
pubmed: 32725955
J Pediatr. 2021 Mar;230:23-31.e10
pubmed: 33197493
JAMA Pediatr. 2020 Sep 1;174(9):868-873
pubmed: 32392288
Dtsch Arztebl Int. 2020 May 22;117(21):373-374
pubmed: 32519943
N Engl J Med. 2020 Apr 30;382(18):1708-1720
pubmed: 32109013
Clin Infect Dis. 2020 Sep 12;71(6):1547-1551
pubmed: 32112072
Nature. 2020 May;581(7809):465-469
pubmed: 32235945
Lancet Infect Dis. 2020 Jun;20(6):669-677
pubmed: 32240634
PLoS One. 2021 Feb 12;16(2):e0246903
pubmed: 33577582
World J Pediatr. 2020 Jun;16(3):240-246
pubmed: 32026148
Lancet. 2020 Feb 15;395(10223):497-506
pubmed: 31986264
BMC Med. 2020 May 6;18(1):123
pubmed: 32370747
Radiology. 2020 Aug;296(2):E115-E117
pubmed: 32073353
Infection. 2021 Oct;49(5):889-905
pubmed: 34170486
Indian Pediatr. 2020 Sep 15;57(9):820-826
pubmed: 32583808

Auteurs

Nashwa M B Eldin (NMB)

Department of Pediatric, Burjeel Hospital, Abu Dhabi, United Arab Emirates.

Maysa Saleh (M)

Pediatric Department, Al Jalila Children's Specialty Hospital, Dubai, United Arab Emirates.

Bahaaeldin Labib (B)

Zayed Military Hospital, Abu Dhabi, United Arab Emirates.

Marwa Othman (M)

Burjeel Hospital, Abu Dhabi, United Arab Emirates.

Lalu Chacko (L)

Burjeel Hospital, Abu Dhabi, United Arab Emirates.

Daphne Mae (D)

Burjeel Hospital, Abu Dhabi, United Arab Emirates.

Lamiaa Elnour (L)

Burjeel Hospital, Abu Dhabi, United Arab Emirates.

Rami H Al-Rifai (RH)

Institute of Public Health, College of Medicine and Health Sciences, Al Ain, United Arab Emirates.

Classifications MeSH